Participation of Mucosal Type I Interferon Signaling in Pulmonary Disease
粘膜 I 型干扰素信号转导参与肺部疾病
基本信息
- 批准号:7706229
- 负责人:
- 金额:$ 23.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnti-Inflammatory AgentsAnti-inflammatoryBacterial InfectionsBacterial PneumoniaCXCL10 geneCell physiologyCellsDendritic CellsEpithelialEpithelial CellsGenesHost DefenseIFNAR1 geneITGAX geneImmuneImmune responseInfectionInflammatoryInfluenzaInterferon Type IInterferonsInterleukin-6LIF geneLungLung diseasesModelingMorbidity - disease rateMusPTPN11 genePathogenesisPhagocytesPhosphorylationPhysiologicalPlayPredispositionProductionPseudomonas aeruginosaReceptor SignalingRecruitment ActivityRegulationRespiratory MucosaRespiratory SystemRespiratory tract structureRoleSecondary toSignal TransductionStaphylococcus aureusStreptococcus pneumoniaeTestingViralVirus Diseaseschemokinecytokineinfluenzavirusmicrobialmortalitymutantpathogenprotective effectresearch studyrespiratoryresponsesuperinfection
项目摘要
DESCRIPTION (provided by applicant): Participation of mucosal type I interferon signaling in pulmonary host defenses mucosal epithelial cells provide both barrier and signaling functions to initiate innate immune responses to bacterial infection in the respiratory tract. Particularly in the airways, the regulation of this initial proinflammatory signaling is critical. In addition to activating NF-?B-dependent proinflammatory genes in response to pathogens, airway mucosal cells also produce type I interferons, IFNs a and ¿ which result in Jak-Stat signaling and the activation of >300 effectors of the IFN-¿ cascade. This cascade is best known for its major role in protection from viral infection, but is likely to have important effects on host defense against bacterial infection as well. In this project we will characterize how common mucosal pathogens, S. pneumoniae, S. aureus and P. aeruginosa activate type I IFN signaling; by identifying the receptors and signaling components that are activated in mucosal epithelial cells and by characterizing how these effectors affect susceptibility to infection. IFN-¿ expression is significantly increased in the airways in response to influenza infection. The local consequences of upregulated IFN-¿ signaling are postulated to enhance susceptibility to secondary bacterial infection, the major cause of influenza- associated mortality. This will be tested in a murine model of influenza, using influenza mutants with differing abilities to stimulate IFN-¿ production and comparing how they affect susceptibility to bacterial superinfection. We predict that mucosal epithelial IFN-¿ production, possibly through effects in activating pulmonary dendritic cells, increases host susceptibility to infection by common bacterial pathogens. Participation of mucosal type I interferon signaling in pulmonary host defenses
RELEVANCE: This project will establish the how common mucosal pathogens, S. pneumoniae, S. aureus and P. aeruginosa activate type I interferon signaling in the respiratory tract. These interferons are critical for effective anti-viral defenses but appear to increase susceptibility to bacterial infection. Activation of this cascade may be an important factor contributing to post-influenza bacterial pneumonia, the major cause of mortality associated with influenza infection.
描述(由应用提供):粘膜I型干扰素信号在肺部防御粘膜上皮细胞中的参与提供屏障和信号传导功能,以引发对呼吸道中细菌感染的先天免疫回报。在气道中,这种初始促炎信号的调节至关重要。除了激活NF-依赖性促炎基因对病原体的响应外,气道粘膜细胞还会产生I型干扰素,IFNS A和¿该级联反应以保护病毒感染的主要作用而闻名,但也可能对宿主防御对细菌感染产生重要影响。在这个项目中,我们将表征常见的粘膜病原体,肺炎链球菌,金黄色葡萄球菌和铜绿假单胞菌激活I型IFN信号传导;通过鉴定在粘膜上皮细胞中激活的受体和信号传导成分,并表征这些作用如何影响感染的易感性。响应影响力的感染,气道中的IFN- - 表达显着增加。更新的IFN-€信号传导的局部后果是为了增强对二次细菌感染的敏感性,这是影响与影响相关的死亡率的主要原因。这将在影响Za的鼠模型中进行测试,使用具有区分能力的影响力突变体刺激IFN-€的产生并比较它们如何影响细菌超级感染的易感性。我们预测,粘膜上皮产生的产生,通过激活肺树突状细胞的作用可能会增加宿主对常见细菌病原体感染的易感性。 I型I型干扰素信号在肺部宿主防御中的参与
相关性:该项目将确定如何在呼吸道中激活I型干扰素信号的常见粘膜病原体,肺炎链球菌,金黄色葡萄球菌和铜绿假单胞菌。这些干扰素对于有效的抗病毒防御措施至关重要,但似乎增加了对细菌感染的敏感性。该级联反应的激活可能是导致肺炎后肺炎后的重要因素,这是与影响力感染相关的死亡率的主要原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alice S Prince其他文献
Alice S Prince的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alice S Prince', 18)}}的其他基金
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
- 批准号:
10534732 - 财政年份:2017
- 资助金额:
$ 23.51万 - 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
- 批准号:
10062515 - 财政年份:2017
- 资助金额:
$ 23.51万 - 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
- 批准号:
10317092 - 财政年份:2017
- 资助金额:
$ 23.51万 - 项目类别:
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
适应宿主的肺部病原体的先天免疫清除
- 批准号:
10532116 - 财政年份:2017
- 资助金额:
$ 23.51万 - 项目类别:
MRSA Activation of Human Keratinocyte Signaling
MRSA 激活人类角质形成细胞信号传导
- 批准号:
8513046 - 财政年份:2013
- 资助金额:
$ 23.51万 - 项目类别:
Staphylococcus aureus exploitation of autophagy promotes latent infection
金黄色葡萄球菌利用自噬促进潜伏感染
- 批准号:
8511238 - 财政年份:2013
- 资助金额:
$ 23.51万 - 项目类别:
MRSA Activation of Human Keratinocyte Signaling
MRSA 激活人类角质形成细胞信号传导
- 批准号:
8660623 - 财政年份:2013
- 资助金额:
$ 23.51万 - 项目类别:
Staphylococcus aureus exploitation of autophagy promotes latent infection
金黄色葡萄球菌利用自噬促进潜伏感染
- 批准号:
8625699 - 财政年份:2013
- 资助金额:
$ 23.51万 - 项目类别:
2012 Biology of Acute Respiratory Infection Gordon Research Conference
2012年急性呼吸道感染生物学戈登研究会议
- 批准号:
8249190 - 财政年份:2012
- 资助金额:
$ 23.51万 - 项目类别:
Participation of Mucosal Type I Interferon Signaling in Pulmonary Disease
粘膜 I 型干扰素信号转导参与肺部疾病
- 批准号:
7862608 - 财政年份:2009
- 资助金额:
$ 23.51万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
- 批准号:
10642598 - 财政年份:2023
- 资助金额:
$ 23.51万 - 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
- 批准号:
10680956 - 财政年份:2023
- 资助金额:
$ 23.51万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 23.51万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 23.51万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 23.51万 - 项目类别: